Bcl-2 inhibition in DLBCL: "the times they are a-changing"?

Blood. 2021 Feb 4;137(5):577-579. doi: 10.1182/blood.2020008924.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bridged Bicyclo Compounds, Heterocyclic
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Proto-Oncogene Proteins c-bcl-2
  • Sulfonamides

Substances

  • Bridged Bicyclo Compounds, Heterocyclic
  • Proto-Oncogene Proteins c-bcl-2
  • Sulfonamides
  • venetoclax